Literature DB >> 19443887

Tissue eosinophilia and its association with tumoral invasion of oral cancer.

Denise Tostes Oliveira1, Kellen Cristine Tjioe, Agnes Assao, Simone Eloiza Sita Faustino, André Lopes Carvalho, Gilles Landman, Luiz Paulo Kowalski.   

Abstract

This study investigated if tumor-associated tissue eosinophilia (TATE) could be associated with the process of tissue invasion in oral squamous cell carcinomas (OSCCs) and its influence on patient's prognosis. Forty-three patients treated for OSCCs with or without lymph nodes involvement, at A. C. Camargo Cancer Hospital, Brazil, were selected for TATE analysis. Two degrees of tissue eosinophilia were established in OSCC: absent/mild and intense. The TATE was evaluated in relation to the clinicopathological features and prognostic value using chi( 2) test and the Kaplan-Meier method. Most of the patients with OSCC in advanced clinical stage presented muscular infiltration and significantly intense TATE whereas those with tumors in early stage frequently showed absent/mild eosinophilia (P = .009). The TATE showed no prognostic value for 5-year and 10-year survival rates of the OSCC. These findings suggest that intense TATE seems to reflect the stromal invasion of the OSCCs that occur in advanced clinical stage.

Entities:  

Mesh:

Year:  2009        PMID: 19443887     DOI: 10.1177/1066896909333778

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  16 in total

1.  Eosinophils may predict occult lymph node metastasis in early oral cancer.

Authors:  D T Oliveira; T P Biassi; S E S Faustino; A L Carvalho; G Landman; L P Kowalski
Journal:  Clin Oral Investig       Date:  2011-12-14       Impact factor: 3.573

2.  Quantitative Evaluation of Tumour--Associated Tissue Eosinophilia and Cyclo-oxegenase-2 Gene in Oral Cancer Patients with Assessment of Long Term Outcomes.

Authors:  N Rakesh; Asha Iyengar; Kuhu Majumdar; G S Vidya; S S Shantha Kumar
Journal:  Pathol Oncol Res       Date:  2015-11-17       Impact factor: 3.201

3.  Primary esophageal sclerosing mucoepidermoid carcinoma with "tissue eosinophilia".

Authors:  Suman Mewa Kinoo; Kapil Maharaj; Bhugwan Singh; Michelle Govender; Pratistadevi Kanaye Ramdial
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

4.  Tumor-associated tissue eosinophilia as a prognostic factor in squamous cell carcinoma of the larynx.

Authors:  D Etit; B G Yardım; S Arslanoğlu; U Bayol; I Cukurova; S Oztürkcan; N Ş Korkmaz
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-12-15

5.  Expression of CD34, VEGFR3 and eosinophil density in selected odontogenic tumors- a pilot study.

Authors:  MohammadSina ArabSheibani; Safoura Seifi; Jahanshah Salehinejad; Ali Bijani
Journal:  J Oral Biol Craniofac Res       Date:  2019-10-03

Review 6.  Tumor associated tissue eosinophilia in oral squamous cell carcinoma: A systematic review and meta-analysis.

Authors:  Nilookumari Choudhary; Gargi S Sarode; Monal Yuwanati; Nikunj Maniyar; Sachin C Sarode; Amol R Gadbail; Shailesh Gondivkar; Shankargouda Patil
Journal:  J Oral Biol Craniofac Res       Date:  2020-11-23

Review 7.  Immune suppression in head and neck cancers: a review.

Authors:  Anaëlle Duray; Stéphanie Demoulin; Pascale Hubert; Philippe Delvenne; Sven Saussez
Journal:  Clin Dev Immunol       Date:  2011-03-10

8.  Tumour associated tissue eosinophilia as a predictor of locoregional recurrence in oral squamous cell carcinoma.

Authors:  Nagaraju Rakesh; Yashoda Devi; Kuhu Majumdar; Sujatha S Reddy; Kunal Agarwal
Journal:  J Clin Exp Dent       Date:  2015-02-01

9.  Eosinophils and oral squamous cell carcinoma: a short review.

Authors:  C P Martinelli-Kläy; B R R N Mendis; T Lombardi
Journal:  J Oncol       Date:  2009-12-16       Impact factor: 4.375

Review 10.  Tumour-associated tissue eosinophilia (TATE) in oral squamous cell carcinoma: a comprehensive review.

Authors:  Marco Mascitti; Lucrezia Togni; Corrado Rubini; Giuseppe Troiano; Lorenzo Lo Muzio; Andrea Santarelli
Journal:  Histol Histopathol       Date:  2020-09-28       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.